换一批Pulmonary Adenocarcinoma Patient with Complex Mutations on EGFR Benefits from Furmonertinib after Acquiring Gefitinib Resistance: A Case Report.
第一作者：
Guixian,Wu
第一单位：
Department of Respiratory and Critical Care Medicine, Taizhou Hospital Zhejiang University, Enze Hospital, Taizhou Enze Medical Center (Group), Taizhou, Zhejiang Province, 318050, China.
作者：
主题词
女(雌)性(Female);人类(Humans);中年人(Middle Aged);肺肿瘤(Lung Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors);突变(Mutation);疾病恶化(Disease Progression);吲哚类(Indoles);吡啶类(Pyridines);嘧啶类(Pyrimidines)
DOI
10.2174/1574892818666230316145232
PMID
38214361
发布时间
2024-01-15
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
